Skip to main content

Gregory P. Samsa

Professor of Biostatistics & Bioinformatics
Biostatistics & Bioinformatics, Division of Biostatistics
Duke Box 2721, Durham, NC 27710
2424 Erwin Road Ste 1105, 11045 Hock Plaza, Durham, NC 27705

Scholarly Works - Conferences


Real-world experience with electronic patient reported outcomes and missing items: "Don't ask me irrelevant questions".

Conference Journal of Clinical Oncology · November 1, 2019 99 Background: Electronic patient-reported outcomes (ePROs) can improve quality of life and prolong survival in patients with cancer by enhancing the detection and tracking of unmet supportive care needs. However, there remain un ... Full text Cite

Patient-reported distress in myelodysplastic syndromes and its relationship with clinical outcomes.

Conference Journal of Clinical Oncology · May 20, 2017 e21564 Background: The National Comprehensive Cancer Network (NCCN) defines distress as an unpleasant emotional experience associated with the psychosocial complications of cancer. Patients with myelodysplastic syndromes (MDS) ar ... Full text Cite

Patient-reported distress in adults with myelodysplastic syndromes (MDS).

Conference Journal of Clinical Oncology · October 9, 2016 80 Background: MDS are hematopoietic malignancies that are incurable in most patients. The National Comprehensive Cancer Network (NCCN) defines distress as an unpleasant emotional experience associated with the psychosocial compl ... Full text Cite

Pilot study of an online app to reduce cancer patients' financial burden.

Conference Journal of Clinical Oncology · May 20, 2016 Full text Cite

Patient-Reported Outcomes After Choice for Contralateral Prophylactic Mastectomy.

Conference J Clin Oncol · May 1, 2016 PURPOSE: The rate of contralateral prophylactic mastectomies (CPMs) continues to rise, although there is little evidence to support improvement in quality of life (QOL) with CPM. We sought to ascertain whether patient-reported outcomes and, more specifical ... Full text Link to item Cite

Physician treatment selection in the prospective Metastatic Renal Cell Cancer (MaRCC) Registry.

Conference Journal of Clinical Oncology · January 10, 2016 563 Background: Clinical trials mRCC pts are different from real world pts, resulting in bias in the literature. The MaRCC Registry is designed to survey questions not asked in tri als, such as why physicians make certain managem ... Full text Cite

Front-line management patterns in the prospective metastatic renal cell cancer (MaRCC) registry.

Conference Journal of Clinical Oncology · January 10, 2016 617 Background: Over the past decade, seven agents were approved for metastatic renal cell carcinoma (mRCC) leading to a rapidly evolving clinical landscape. Clinical trials addressing treatment efficacy, sequencing, and other qu ... Full text Cite

Severity of and contributors to distress in patients with acute myeloid leukemia (AML) receiving induction chemotherapy.

Conference Journal of Clinical Oncology · October 10, 2015 83 Background: Distress screening is a recommended component of comprehensive cancer care, and is now required as a condition of cancer center accreditation by the American College of Surgeons Commission on Cancer. However, the e ... Full text Cite

A national snapshot of satisfaction with breast cancer procedures.

Conference Ann Surg Oncol · February 2015 PURPOSE: Women with early-stage breast cancer face the complex decision to undergo one of three equally effective oncologic surgical strategies: breast-conservation surgery with radiation (BCS), mastectomy, or mastectomy with breast reconstruction. With co ... Full text Link to item Cite

Does cancer treatment-related financial distress worsen over time?

Conference Journal of Clinical Oncology · May 20, 2014 Full text Cite

Patient-oncologist cost communication, financial distress, and medication adherence.

Conference Journal of Clinical Oncology · November 1, 2013 2 Background: Little is known about the association between patient-oncologist discussion of cancer treatment out-of-pocket (OOP) cost and medication adherence, a critical component of quality cancer care. Methods: We conducted a ... Full text Cite

The financial burden of cancer care: Do patients know what to expect?

Conference JOURNAL OF CLINICAL ONCOLOGY · May 20, 2013 Link to item Cite

Point of Care Monitoring of the International Normalized Ratio in Patients with Antiphospholipid Antibodies.

Conference Blood · November 16, 2004 AbstractWarfarin is effective in decreasing recurrent thrombosis in patients with antiphospholipid antibody syndrome (APS). Antiphospholipid antibodies (APAs) can influence the results of clotting tests in a ... Full text Cite

Improving headache care: Impact of a disease management program

Conference ANNALS OF NEUROLOGY · September 1, 2001 Link to item Cite

A randomized trial to evaluate genetic susceptibility feedback to motivate smoking cessation.

Conference CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION · February 2001 Link to item Cite

VARIATION IN BREAST-CANCER SCREENING RECOMMENDATIONS WITH NURSING-HOME RESIDENCE AND FUNCTION

Conference JOURNAL OF THE AMERICAN GERIATRICS SOCIETY · September 1995 Link to item Cite

TOPICAL BETA-BLOCKERS AND PLASMA-LIPIDS - CARTEOLOL VS TIMOLOL

Conference INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE · March 15, 1993 Link to item Cite

RISK-FACTORS FOR NOSOCOMIAL PNEUMONIA IN THE ELDERLY

Conference JOURNAL OF THE AMERICAN GERIATRICS SOCIETY · August 1991 Link to item Cite

METHOD FOR ASSESSING THE APPROPRIATENESS OF DRUG-THERAPY

Conference JOURNAL OF THE AMERICAN GERIATRICS SOCIETY · August 1991 Link to item Cite

CHARACTERISTICS OF AGING SPINAL-CORD INJURED VETERANS

Conference JOURNAL OF THE AMERICAN GERIATRICS SOCIETY · August 1990 Link to item Cite

SURVIVAL OF LONG-TERM SPINAL-CORD INJURED VETERANS

Conference CLINICAL RESEARCH · April 1990 Link to item Cite

ATYPICAL SQUAMOUS METAPLASIA AS A RISK FACTOR FOR BRONCHOGENIC-CARCINOMA

Conference AMERICAN JOURNAL OF EPIDEMIOLOGY · October 1988 Link to item Cite

SELECTIVE VULNERABILITY AMONG SCHWANN CELLS TO TELLURIUM-INDUCED DEMYELINATION

Conference Journal of Neuropathology and Experimental Neurology · May 1986 Full text Cite